Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study (Q43813854)

27 November 2017

title

Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study (English)

1 reference

familial combined hyperlipidemia

27 November 2017

1 reference

1 reference

1 reference

McNeely MJ

1

1 reference

27 November 2017

Edwards KL

2

1 reference

27 November 2017

Marcovina SM

3

1 reference

27 November 2017

Brunzell JD

4

1 reference

27 November 2017

Motulsky AG

5

1 reference

27 November 2017

Austin MA

6

1 reference

27 November 2017

publication date

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

159

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

471-481

1 reference

Family study of serum lipids and lipoproteins in coronary heart-disease

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Myocardial infarction in the familial forms of hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Familial lipoprotein disorders in patients with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Genetics of lipoprotein disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Relationship of insulin sensitivity and ApoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

LDL physical and chemical properties in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: Normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Acute myocardial infarction in young adults: Prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-ter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: the Bogalusa Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. The Shibata Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

The hyperlipemic effect of a low-fat, high-carbohydrate diet in diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Phenotype expression in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

One measurement of serum total cholesterol is enough to predict future levels in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Year-to-year variability of cholesterol levels in a pediatric practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Evaluating cholesterol screening. The importance of controlling for regression to the mean

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Novel genes for familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900528-7

10.1016/S0021-9150(01)00528-7

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference